Roche Loses Bid To Block Generic Boniva

Law360, New York (March 14, 2012, 5:47 PM EDT) -- Pharmaceutical giant Hoffmann-La Roche Inc. lost a bid Wednesday to block Apotex Inc., Mylan Inc. and other generic-drug makers from releasing a version of the osteoporosis drug Boniva after a judge ruled Roche would have difficulty withstanding challenges to two of the drug's patents.

Judge Stanley R. Chesler of the New Jersey federal court blocked Roche's bid for a preliminary injunction, finding the drug manufacturer's suit did not show a likelihood of success on the merits on the validity of U.S. Patent Numbers 7,718,634 and 7,410,957....
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.